Keyphrases
Neuropathy
100%
Diabetes Type 1
100%
Placebo-controlled Trial
100%
Gastrointestinal
100%
Fecal Microbiota Transplantation
100%
Patients with Diabetes
100%
Placebo
60%
Adverse Events
40%
Type I Diabetes
30%
Gastrointestinal Diseases
30%
Type 1 Diabetes Mellitus (T1DM)
30%
Diarrhea
20%
Irritable Bowel Syndrome
20%
Bloating
20%
Bray-Curtis
12%
Colon Biopsy
12%
Alistipes
12%
Gastroenteropathy
10%
Food Color
10%
Severity Grading
10%
Public Trial
10%
Diabetic Enteropathy
10%
Common Terminology Criteria for Adverse Events (CTCAE)
10%
Clinical Outcomes
10%
Symptom Severity
10%
Abdominal Pain
10%
Placebo-controlled
10%
Patient Assessment
10%
Quality of Life
10%
Feces
10%
Impact Scale
10%
Trial Registration
10%
Nausea-vomiting
10%
Severity Index
10%
Serious Adverse Events
10%
Moderate to Severe
10%
Current Therapies
10%
Constipation
10%
Placebo Groups
10%
Bowel Dysfunction
10%
Gastrointestinal Symptom Rating Scale
10%
Glycerol
10%
Steno
10%
Medicine and Dentistry
Patient with Type 1 Diabetes
100%
Placebo
100%
Fecal Microbiota Transplantation
100%
Neuropathy
100%
Adverse Event
60%
Gastrointestinal Distress
40%
Gastrointestinal Disease
20%
Diarrhea
20%
Bloating
20%
Irritable Bowel Syndrome
20%
Constipation
10%
Feces
10%
Table Salt
10%
Nausea
10%
Insulin Dependent Diabetes Mellitus
10%
Abdominal Pain
10%
Quality of Life
10%
Patient Assessment
10%
Single Drug Dose
10%
Rating Scale
10%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Neuropathy
100%
Feces microflora
100%
Insulin Dependent Diabetes Mellitus
100%
Adverse Event
60%
Gastrointestinal Symptom
40%
Bloating
20%
Gastrointestinal Disease
20%
Diarrhea
20%
Irritable Colon
20%
Constipation
10%
Abdominal Pain
10%
Table Salt
10%
Nausea
10%
